Inventor
ABRAHAM DONALD J
US33 patents
⚠️ This page may combine multiple inventors who share the name “ABRAHAM DONALD J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV VIRGINIA COMMONWEALTH
10 patentsUS5927283AJul 27, 1999
Allosteric modifiers of hemoglobin
UNIV VIRGINIA COMMONWEALTH47 citations96
US5731454AMar 24, 1998
Allosteric modifiers of hemoglobin useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood
UNIV VIRGINIA COMMONWEALTH51 citations94
US5648375AJul 15, 1997
Use of hydrophobic compounds and anesthetics in combination with allosteric hemoglobin modifiers
UNIV VIRGINIA COMMONWEALTH40 citations92
US6214879B1Apr 10, 2001
Allosteric inhibitors of pyruvate kinase
UNIV VIRGINIA COMMONWEALTH44 citations91
US5872282AFeb 16, 1999
Allosteric modifiers of hemoglobin
UNIV VIRGINIA COMMONWEALTH31 citations91
US5668182ASep 16, 1997
Method of calming or sedating an animal with a hydroxy benzaldehyde compound
UNIV VIRGINIA COMMONWEALTH24 citations83
US5661182AAug 26, 1997
Method for lowering oxygen affinity of hemoglobin in redcell suspensions, in whole blood and in vivo
UNIV VIRGINIA COMMONWEALTH18 citations81
US5248785ASep 28, 1993
Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
UNIV VIRGINIA COMMONWEALTH17 citations73
US6486342B1Nov 26, 2002
Substituted chiral allosteric hemoglobin modifiers
UNIV VIRGINIA COMMONWEALTH13 citations70
US7119208B2Oct 10, 2006
Anti-sickling agents
UNIV VIRGINIA COMMONWEALTH5 citations61
INNOVATIVE TECH CENTER
10 patentsUS5677330AOct 14, 1997
Medical uses of allosteric hemoglobin modifier compounds in patient care
INNOVATIVE TECH CENTER73 citations96
US5382680AJan 17, 1995
Allosteric hemoglobin modifier compounds
INNOVATIVE TECH CENTER58 citations95
US5432191AJul 11, 1995
Allosteric hemoglobin modifiers to decrease oxygen affinity in blood
INNOVATIVE TECH CENTER56 citations94
US5122539AJun 16, 1992
Allosteric hemoglobin modifiers useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood
INNOVATIVE TECH CENTER70 citations94
US5705521AJan 6, 1998
Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors
INNOVATIVE TECH CENTER56 citations92
US5049695ASep 17, 1991
Allosteric hemoglobin modifiers
INNOVATIVE TECH CENTER46 citations91
US5591892AJan 7, 1997
Allosteric modifiers of hemoglobin
INNOVATIVE TECH CENTER40 citations90
US5599974AFeb 4, 1997
Aldehydic agents for allosteric modification of hemoglobin
INNOVATIVE TECH CENTER18 citations81
US5827888AOct 27, 1998
Perinatal treatment of a fetus to avoid oxygen deprivation
INNOVATIVE TECH CENTER15 citations73
US5250701AOct 5, 1993
Allosteric hemoglobin modifiers which decrease oxygen affinity in blood
INNOVATIVE TECH CENTER14 citations73
MERCK & CO INC
4 patentsUS4751244AJun 14, 1988
Compounds useful in treating sickle cell anemia
MERCK & CO INC70 citations96
US4731381AMar 15, 1988
Method of treating a person for sickle cell anemia
MERCK & CO INC73 citations96
US4731473AMar 15, 1988
Compounds useful in treating sickle cell anemia
MERCK & CO INC58 citations96
US4699926AOct 13, 1987
Compounds useful in treating sickle cell anemia
MERCK & CO INC63 citations96
UNIV PITTSBURGH
4 patentsUS4795627AJan 3, 1989
Tritium labelled N-mustard type compounds and a process for their production
UNIV PITTSBURGH63 citations94
US4887995ADec 19, 1989
Method of treating sickle cell anemia
UNIV PITTSBURGH26 citations92
US4482571ANov 13, 1984
Sickle cell anemia treatment and compound
UNIV PITTSBURGH30 citations92
US4704402ANov 3, 1987
Method of treating sickle cell anemia
UNIV PITTSBURGH45 citations87